Latest Supply Chain Management News

The Calmer Co (ASX – CCO) reported an impressive $8 million revenue for FY25, marking 86% year-over-year growth and positioning itself as a global leader in the emerging kava market. With expanding retail presence and strong US sales, the company is on track to break even in 2026.

Zimi Limited has completed its manufacturing transition, fulfilling over $1 million in backorders and restoring product availability in the Australian smart home market.

RooLife Group has inked a $64 million two-year supply agreement to expand its branded coffee products in China, tapping into the country’s rapidly growing coffee market. The deal leverages established suppliers and distribution partners to accelerate RLG’s e-commerce-driven growth strategy.

Myer Group posted modest sales growth in FY25, buoyed by the Apparel Brands acquisition, but faced profitability challenges from operational disruptions and macroeconomic pressures. The Group is advancing its omni-channel strategy and cost management initiatives while addressing National Distribution Centre issues.

Clover Corp has reported a standout FY25 with robust revenue and profit growth, driven by new product launches and strategic investments that strengthen its global supply chain and market reach.

Renascor Resources has begun construction of its Purified Spherical Graphite demonstration facility in Adelaide, aiming to showcase an innovative HF-free purification process and disrupt China’s near-monopoly on PSG supply.

Magontec Limited reports a $5.25 million interim gross profit and a doubling of net assets per share to 84 cents, despite an underlying net loss. The company is banking on new Chinese supply partnerships and automation to restore profitability by FY 2026.

GLG Corp has significantly revised its profit guidance for FY2025, now expecting a net loss of up to $1.5 million, a sharp increase from earlier estimates.

Brambles Limited reported a robust 10% increase in underlying profit for FY25, driven by sales growth and asset efficiency, while announcing a US$400 million share buy-back for FY26. The company also outlined a positive outlook with continued digital transformation and sustainability progress.

McPherson’s Limited has finalized a key pharmacy wholesaler agreement with API Services Australia, marking the completion of its new distribution model and transitioning significant revenue previously handled direct-to-store.

Papyrus Australia appoints Daniel Schmidt as CEO to lead its transition from R&D to commercial operations, alongside a strategic restructure to support growth.

RooLife Group has secured a two-year supply agreement with Eternal Asia, granting access to over one million retail outlets across China and potential annual orders worth up to AUD 110 million.